AGPAT2 anticorps
-
- Antigène Voir toutes AGPAT2 Anticorps
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp AGPAT2 est non-conjugé
-
Application
- Western Blotting (WB), Immunofluorescence (IF)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- Recombinant fusion protein of human AGPAT2 (NP_006403.2).
- Isotype
- IgG
- Top Product
- Discover our top product AGPAT2 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000 IF 1:50-1:100
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
- Autre désignation
- AGPAT2 (AGPAT2 Produits)
- Synonymes
- anticorps AGPAT2, anticorps zgc:153984, anticorps 1-agpat2, anticorps bscl, anticorps bscl1, anticorps lpaab, anticorps lpaat-beta, anticorps 1-AGPAT2, anticorps BSCL, anticorps BSCL1, anticorps LPAAB, anticorps LPAAT-beta, anticorps 2510002J07Rik, anticorps AV000834, anticorps 1-acylglycerol-3-phosphate O-acyltransferase 2, anticorps 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta), anticorps AGPAT2, anticorps agpat2, anticorps Agpat2
- Sujet
- This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
- Poids moléculaire
-
Observed_MW: 31 kDa
Calculated_MW: 27 kDa/30 kDa
- ID gène
- 10555
- UniProt
- O15120
-